Drug Metabolism and Bioanalysis
The scope includes in vitro systems, including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; bioactivation; recent developments for the identification of drug metabolites, reactive intermediate, and glutathione conjugates.
Additionally, LC/MS and other key detection methods, including ligand binding assays, sample preparation, chromatography and separation sciences, and method development and validation, are included, with applications in drug and metabolite assays, pharmacokinetic/toxicokinetic assays, biomarker assays, immunogenicity assays, diagnostic assays. Topics covered in this interdisciplinary journal include:
- Analytical Method and Drug Metabolism
- Bioavailability and Biopharmacy
- Cytochrome 450 Drug Metabolism
- Cytotoxicity
- Drug Absorption and Disposition
- Drug Biotransformation
- Drug Delivery System
- Drug-Drug Interaction
- Drug Food Interaction
- Drug Metabolizing Enzymes
- Drug Toxicology
- Drug Transporters
- Drugs and CYP2D6
- Factors Affecting Drug Metabolism
- Hepatic Metabolism of Drugs
- P-Glycoprotein and Transport Carriers
- Pharmacokinetics and Pharmacodynamics
- Phase I and II Drug Metabolism
- Reactive Metabolites
- Therapeutic Drug Monitoring
- Xenobiotics
Editor-in-Chief:
-
Zhiyang ZhaoResolian
Malvern, PA
United States of America
ISSN: 3117-3853 (Print)
eISSN: 3117-3861 (Online)